These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 9250168

  • 21. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
    Chang SW.
    J Lab Clin Med; 1994 Jan; 123(1):65-72. PubMed ID: 8288963
    [Abstract] [Full Text] [Related]

  • 22. Nitric oxide modulates hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S, Sellers LA, Gherardi E, Sasisekharan R, Fan TP.
    Angiogenesis; 2004 Jan; 7(4):285-94. PubMed ID: 15886872
    [Abstract] [Full Text] [Related]

  • 23. Nitric oxide induces angiogenesis and upregulates alpha(v)beta(3) integrin expression on endothelial cells.
    Lee PC, Kibbe MR, Schuchert MJ, Stolz DB, Watkins SC, Griffith BP, Billiar TR, Shears LL.
    Microvasc Res; 2000 Nov; 60(3):269-80. PubMed ID: 11078643
    [Abstract] [Full Text] [Related]

  • 24. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
    Sonveaux P, Martinive P, DeWever J, Batova Z, Daneau G, Pelat M, Ghisdal P, Grégoire V, Dessy C, Balligand JL, Feron O.
    Circ Res; 2004 Jul 23; 95(2):154-61. PubMed ID: 15205364
    [Abstract] [Full Text] [Related]

  • 25. Platelet activating factor modulates microvascular permeability through nitric oxide synthesis.
    Ramírez MM, Quardt SM, Kim D, Oshiro H, Minnicozzi M, Durán WN.
    Microvasc Res; 1995 Sep 23; 50(2):223-34. PubMed ID: 8538502
    [Abstract] [Full Text] [Related]

  • 26. Platelet-activating factor antagonists suppress the generation of tumor necrosis factor-alpha and superoxide induced by lipopolysaccharide or phorbol ester in rat liver macrophages.
    Zhang F, Decker K.
    Eur Cytokine Netw; 1994 Sep 23; 5(3):311-7. PubMed ID: 7948767
    [Abstract] [Full Text] [Related]

  • 27. Interaction of estrogen and tumor necrosis factor alpha in endothelial cell migration and early stage of angiogenesis.
    Florian M, Florianova L, Hussain S, Magder S.
    Endothelium; 2008 Sep 23; 15(5-6):265-75. PubMed ID: 19065318
    [Abstract] [Full Text] [Related]

  • 28. Nitric oxide mediates the mitogenic effects of insulin and vascular endothelial growth factor but not of leptin in endothelial cells.
    Józkowicz A, Pankiewicz J, Dulak J, Partyka L, Wybrańska I, Huk I, Dembińska-Kieć A.
    Acta Biochim Pol; 1999 Sep 23; 46(3):703-15. PubMed ID: 10698278
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of sphingosine-1-phosphate- and vascular endothelial growth factor-induced endothelial cell chemotaxis by red grape skin polyphenols correlates with a decrease in early platelet-activating factor synthesis.
    Barthomeuf C, Lamy S, Blanchette M, Boivin D, Gingras D, Béliveau R.
    Free Radic Biol Med; 2006 Feb 15; 40(4):581-90. PubMed ID: 16458188
    [Abstract] [Full Text] [Related]

  • 30. Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality.
    Libert C, Van Molle W, Brouckaert P, Fiers W.
    J Inflamm; 2006 Feb 15; 46(3):139-43. PubMed ID: 8844494
    [Abstract] [Full Text] [Related]

  • 31. Direct measurement of VEGF-induced nitric oxide production by choroidal endothelial cells.
    Uhlmann S, Friedrichs U, Eichler W, Hoffmann S, Wiedemann P.
    Microvasc Res; 2001 Sep 15; 62(2):179-89. PubMed ID: 11516247
    [Abstract] [Full Text] [Related]

  • 32. Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis.
    Montrucchio G, Lupia E, Battaglia E, Passerini G, Bussolino F, Emanuelli G, Camussi G.
    J Exp Med; 1994 Jul 01; 180(1):377-82. PubMed ID: 7516414
    [Abstract] [Full Text] [Related]

  • 33. TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury.
    Gao X, Xu X, Belmadani S, Park Y, Tang Z, Feldman AM, Chilian WM, Zhang C.
    Arterioscler Thromb Vasc Biol; 2007 Jun 01; 27(6):1269-75. PubMed ID: 17413034
    [Abstract] [Full Text] [Related]

  • 34. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC, Wood J, Mandriota SJ, Schnell C, Ferrari S, Mestan J, Zhu Z, Witte L, Pepper MS.
    J Pharmacol Exp Ther; 2001 Dec 01; 299(3):1073-85. PubMed ID: 11714897
    [Abstract] [Full Text] [Related]

  • 35. The intravenous administration of tumor necrosis factor alpha, interleukin 8 and macrophage-derived neutrophil chemotactic factor inhibits neutrophil migration by stimulating nitric oxide production.
    Tavares-Murta BM, Cunha FQ, Ferreira SH.
    Br J Pharmacol; 1998 Aug 01; 124(7):1369-74. PubMed ID: 9723947
    [Abstract] [Full Text] [Related]

  • 36. Augmentation of tumor metastasis by platelet-activating factor.
    Im SY, Ko HM, Kim JW, Lee HK, Ha TY, Lee HB, Oh SJ, Bai S, Chung KC, Lee YB, Kang HS, Chun SB.
    Cancer Res; 1996 Jun 01; 56(11):2662-5. PubMed ID: 8653713
    [Abstract] [Full Text] [Related]

  • 37. Involvement of matrix metalloproteinase-9 in platelet-activating factor-induced angiogenesis.
    Ko HM, Park YM, Jung B, Kim HA, Choi JH, Park SJ, Lee HK, Im SY.
    FEBS Lett; 2005 Apr 25; 579(11):2369-75. PubMed ID: 15848174
    [Abstract] [Full Text] [Related]

  • 38. The effects of the inhibition of inducible nitric oxide synthase on angiogenesis of epithelial ovarian cancer.
    Malone JM, Saed GM, Diamond MP, Sokol RJ, Munkarah AR.
    Am J Obstet Gynecol; 2006 Apr 25; 194(4):1110-6; discussion 1116-8. PubMed ID: 16580304
    [Abstract] [Full Text] [Related]

  • 39. Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat.
    MacKendrick W, Caplan M, Hsueh W.
    Pediatr Res; 1993 Aug 25; 34(2):222-8. PubMed ID: 8233729
    [Abstract] [Full Text] [Related]

  • 40. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.
    Rabinovici R, Yue TL, Farhat M, Smith EF, Esser KM, Slivjak M, Feuerstein G.
    J Pharmacol Exp Ther; 1990 Oct 25; 255(1):256-63. PubMed ID: 2213560
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.